![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Real-world Data on Long-term Quality Of Life After
Glecaprevir/Pibrentasvir Therapy: Data From the German Hepatitis C Registry (DHC-R)
|
|
|
EASL 2023 June 21-24 Vienna &
Markus Cornberg1, Albrecht Stoehr2, Dennis Hidde3, Gerd Klausen4, Willibold Schiffelholz5,
Thomas Lutz6, Manfred Nowak7, Michelle Collins8, Karl-Georg Simon9
1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; 2IFI Medizin GmbH, Hamburg, Germany; 3AbbVie Germany GmbH & Co. KG, Wiesbaden, Germany; 4Schwerpunktpraxis für Infektionsmedizin am Oranienburger Tor, Berlin, Germany; 5Gastroenterologische Schwerpunktpraxis, Augsburg, Germany; 6Infektiologikum, Frankfurt, Germany; 7f Therapieverbund Ludwigsmühle, Schwerpunktpraxis Landau/Pfalz, Germany; 8AbbVie Inc., North Chicago, Illinois, USA; 9MVZ Dres Eisenbach/Simon/ Schwarz/GbR, Leverkusen, Germany
![0625231](../images/062523/062523-9/0625231.gif)
![0625232](../images/062523/062523-9/0625232.gif)
![0625233](../images/062523/062523-9/0625233.gif)
![0625234](../images/062523/062523-9/0625234.gif)
![0625235](../images/062523/062523-9/0625235.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|